SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Lili Boulanger Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientLili Boulanger
Date of birth1893-08-21
IdentifiersMRN HR-ET025-SYN-TD; SSN (made up) 000-25-7731
Document date2026-11-01
AuthorOdile Marchetti-Rowe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit for four months of abdominal pain, diarrhea, fevers, and weight loss. Concerns: Four months of cramping pain low on the right of the abdomen, loose stools up to six times a day and at night, evening fevers, and weight loss; Has been unwell, on and off, since childhood and wants a clear answer and a plan that lets her keep composing and performing. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one or two tablets by mouth up to every 6 hours as needed for abdominal pain, no more than 3000 mg a day; no nonsteroidal anti-inflammatory drugsOne or two tablets up to every 6 hours as neededOral route1914-12-15activeS
Prednisone 20 mg oral tablet: 40 mg by mouth each morning, reduced by 5 mg each week over eight weeks, as a bridge until risankizumab takes effect40 mg each morning, tapering by 5 mg weeklyOral route1915-01-28 to 1915-03-24completedS
Risankizumab 600 mg in 10 mL intravenous infusion over at least one hour at weeks 0, 4, and 8 (induction)One infusion every 4 weeks for three dosesIntravenous route1915-02-02 to 1915-04-26completedS
Risankizumab 360 mg in 2.4 mL by subcutaneous on-body injector every 8 weeks (maintenance), from week 12One injection every 8 weeksSubcutaneous route1915-04-27activeS
Ferric derisomaltose 1000 mg in 10 mL intravenous infusion, single doseSingle infusionIntravenous route1915-02-02 to 1915-02-02completedS
Cholecalciferol (vitamin D3) 1889 units oral tablet, one tablet by mouth once dailyOne tablet once dailyOral route1915-01-28activeS
Calcium carbonate 1250 mg (500 mg elemental calcium) oral tablet, one tablet by mouth once daily with food while on prednisoneOne tablet daily with foodOral route1915-01-28 to 1915-03-24completedS

Procedures

ProcedureDatesStatusEvidence
Chest X-ray before possible immunosuppression and to look for tuberculosis: normal lungs, no hilar nodes, no calcified granulomas1915-01-21 to 1915-01-21completedS
Ileocolonoscopy with biopsies: deep longitudinal ulcers over the last 15 cm of the terminal ileum; patchy aphthous and serpiginous ulcers in the ascending and transverse colon with normal mucosa between; rectum spared; ileocecal valve patulous, not stenosed; SES-CD 14. Biopsies: chronic active ileitis and colitis with crypt architectural distortion and a few small non-caseating granulomas; acid-fast stain negative, TB PCR (Xpert MTB/RIF) negative; mycobacterial culture sent1915-01-23 to 1915-01-23completedS
MR enterography: 18 cm of terminal ileal wall thickening (7 mm) with mucosal hyperenhancement and the comb sign; no stricture with upstream dilation, no fistula, abscess, or necrotic lymph nodes; no ascites; ascending colon wall thickening1915-01-26 to 1915-01-26completedS
Baseline bone density scan (DXA): lumbar spine Z-score -1.4, femoral neck Z-score -1.1, within the expected range for age1915-01-28 to 1915-01-28completedS
Follow-up ileocolonoscopy eight months into risankizumab: healed ileal ulcers with a few small aphthae and scarring; colon healed; SES-CD 2 (endoscopic response, near remission); no stricture1915-10-05 to 1915-10-05completedS

Immunizations

DateVaccineStatusEvidence
1914-10-20Influenza vaccine, 1914-1915 seasoncompletedS
1905-09-12Tdap vaccinecompletedS
1915-01-28Pneumococcal conjugate vaccine PCV20, before immunosuppressioncompletedS
1915-01-28Recombinant zoster vaccine, dose 1 of 2, before immunosuppressioncompletedS
1915-01-28Hepatitis B vaccine, adult booster dose (infant series, anti-HBs below 10 mIU/mL)completedS
1915-04-27Recombinant zoster vaccine, dose 2 of 2completedS
1915-10-19Influenza vaccine, 1915-1916 seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1895Pneumonia at about two years old, described as bronchial pneumonia, with frail health afterwardsD (CLM-0003)
Early 1915Headaches, loss of appetite, fever, and symptoms resembling colitis and appendicitis, with much time in bedD (CLM-0007)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
Four months of cramping pain low on the right of the abdomen, loose stools up to six times a day and at night, evening fevers, and weight lossactiveS
Has been unwell, on and off, since childhood and wants a clear answer and a plan that lets her keep composing and performingactiveS

Assessment

Most recent measures: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1915-10-19; Hemoglobin [Mass/volume] in Blood 13.1 on 1915-08-03; MCV [Entitic mean volume] in Red Blood Cells by Automated count 83 on 1915-04-27; Leukocytes [#/volume] in Blood by Automated count 9.4 on 1915-04-13; Platelets [#/volume] in Blood by Automated count 452 on 1915-01-19; C reactive protein [Mass/volume] in Serum or Plasma 11 on 1915-04-13; Calprotectin [Mass/mass] in Stool 42 on 1915-08-03; Albumin [Mass/volume] in Serum or Plasma 4.3 on 1915-08-03; Ferritin [Mass/volume] in Serum or Plasma 72 on 1915-08-03; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 340 on 1915-08-03; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 on 1915-04-27; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 on 1915-04-13; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 on 1915-04-27; Creatinine [Mass/volume] in Serum or Plasma 0.9 on 1915-04-13; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 1915-08-03; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 6 on 1915-03-02; Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 on 1915-04-27; DXA Lumbar spine [Z-score] Bone density -1.4 on 1915-01-28; DXA Femur [Z-score] Bone density -1.1 on 1915-01-28; Phosphate [Mass/volume] in Serum or Plasma 3 on 1915-03-02; Potassium [Moles/volume] in Serum or Plasma 3.4 on 1915-04-13; Total score [AUDIT-C] 0 on 1915-10-19 [S]

Strengths and supports: Supports: close friends and fellow musicians; her teachers at the conservatory [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Crohn disease of the terminal ileum and colon (ileocolitis), Montreal A2 L3 B1 without perianal disease, moderate to severe: deep ileal ulcers over 15 cm and patchy colonic ulcers, SES-CD 14, Harvey-Bradshaw Index 11; intestinal tuberculosis excluded by negative interferon-gamma release assay, normal chest X-ray, and biopsies negative for acid-fast bacilli, TB PCR, and mycobacterial culture; synthetic modern diagnosis linked to her documented chronic intestinal illness, whose historical diagnosis is not settledactiveconfirmed K50.80S — Synthetic diagnosis confirmed within the modern episode; her historical illness is documented (D), but whether it was intestinal tuberculosis or Crohn disease remains a retrospective interpretation (R) and is disputed.
Four months of crampy right lower abdominal pain, loose stools up to six times a day including at night, low-grade evening fevers, and loss of 6 kg; inflammatory markers raised; colonoscopy and small-bowel imaging bookedresolvedconfirmed R19.7S — Synthetic presenting concern at the index visit, superseded by the diagnosis; the documented symptoms of early 1915 are echoed (D).
Iron deficiency anemia from chronic intestinal blood loss and poor absorption (hemoglobin 10.6 g/dL, MCV 76, ferritin 9)resolvedconfirmed D50.0S — Synthetic finding at presentation; corrected by intravenous iron.
Moderate protein-calorie malnutrition: BMI 17.6 after losing 6 kg (12 percent of body weight) in four months; albumin 3.3 g/dLresolvedconfirmed E44.0S — Synthetic nutritional status at presentation; resolved with treatment and dietitian support.
Vitamin D deficiency (25-hydroxyvitamin D 18 ng/mL)resolvedconfirmed E55.9S — Synthetic finding at presentation.
Long-term use of risankizumab, an immunosuppressive biologic, for Crohn diseaseactiveconfirmed Z79.620S — Synthetic treatment status.
Acute norovirus gastroenteritis on risankizumab, with mild dehydration; distinguished from a Crohn flare by the sudden onset, household contacts, and a positive stool PCR; resolved in three daysresolvedconfirmed A08.11S — Synthetic common infection that teaches the difference between infection and a flare in treated Crohn disease; it does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1915-01-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]2{score}S
1915-01-19Hemoglobin [Mass/volume] in Blood10.6g/dL12-15.5 g/dLLowS
1915-01-19MCV [Entitic mean volume] in Red Blood Cells by Automated count76fL80-100 fLLowS
1915-01-19Leukocytes [#/volume] in Blood by Automated count9.810*3/uL4-11 10*3/uLNormalS
1915-01-19Platelets [#/volume] in Blood by Automated count45210*3/uL150-400 10*3/uLHighS
1915-01-19C reactive protein [Mass/volume] in Serum or Plasma38mg/L<=5 mg/LHighS
1915-01-19Calprotectin [Mass/mass] in Stool1240ug/g<=50 ug/gHighS
1915-01-19Albumin [Mass/volume] in Serum or Plasma3.3g/dL3.5-5 g/dLLowS
1915-01-19Ferritin [Mass/volume] in Serum or Plasma9ng/mL15-150 ng/mLLowS
1915-01-19Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma310pg/mL200-900 pg/mLNormalS
1915-01-1925-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma18ng/mL30-100 ng/mLLowS
1915-01-19Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma16U/L<=33 U/LNormalS
1915-01-19Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma19U/L<=32 U/LNormalS
1915-01-19Creatinine [Mass/volume] in Serum or Plasma0.7mg/dL0.5-1.1 mg/dLNormalS
1915-01-28Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
1915-01-28Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]9{score}S
1915-01-28Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma18U/L<=33 U/LNormalS
1915-01-28Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma20U/L<=32 U/LNormalS
1915-01-28Bilirubin.total [Mass/volume] in Serum or Plasma0.4mg/dL<=1.2 mg/dLNormalS
1915-01-28DXA Lumbar spine [Z-score] Bone density-1.4{Z-score}A Z-score of -2.0 or below is below the expected range for ageNormalS
1915-01-28DXA Femur [Z-score] Bone density-1.1{Z-score}A Z-score of -2.0 or below is below the expected range for ageNormalS
1915-03-02Hemoglobin [Mass/volume] in Blood11.6g/dL12-15.5 g/dLLowS
1915-03-02C reactive protein [Mass/volume] in Serum or Plasma8mg/L<=5 mg/LHighS
1915-03-02Albumin [Mass/volume] in Serum or Plasma3.7g/dL3.5-5 g/dLNormalS
1915-03-02Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L<=33 U/LNormalS
1915-03-02Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L<=32 U/LNormalS
1915-03-02Bilirubin.total [Mass/volume] in Serum or Plasma0.5mg/dL<=1.2 mg/dLNormalS
1915-03-02Phosphate [Mass/volume] in Serum or Plasma3mg/dL2.5-4.5 mg/dLNormalS
1915-03-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
1915-03-02Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]6{score}S
1915-04-27Hemoglobin [Mass/volume] in Blood12.6g/dL12-15.5 g/dLNormalS
1915-04-27MCV [Entitic mean volume] in Red Blood Cells by Automated count83fL80-100 fLNormalS
1915-04-27Ferritin [Mass/volume] in Serum or Plasma86ng/mL15-150 ng/mLNormalS
1915-04-27C reactive protein [Mass/volume] in Serum or Plasma3mg/L<=5 mg/LNormalS
1915-04-27Calprotectin [Mass/mass] in Stool210ug/g<=50 ug/gHighS
1915-04-27Albumin [Mass/volume] in Serum or Plasma4.1g/dL3.5-5 g/dLNormalS
1915-04-27Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma19U/L<=33 U/LNormalS
1915-04-27Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L<=32 U/LNormalS
1915-04-27Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL<=1.2 mg/dLNormalS
1915-04-2725-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma34ng/mL30-100 ng/mLNormalS
1915-08-03Hemoglobin [Mass/volume] in Blood13.1g/dL12-15.5 g/dLNormalS
1915-08-03Ferritin [Mass/volume] in Serum or Plasma72ng/mL15-150 ng/mLNormalS
1915-08-03Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma340pg/mL200-900 pg/mLNormalS
1915-08-03C reactive protein [Mass/volume] in Serum or Plasma2mg/L<=5 mg/LNormalS
1915-08-03Calprotectin [Mass/mass] in Stool42ug/g<=50 ug/gNormalS
1915-08-03Albumin [Mass/volume] in Serum or Plasma4.3g/dL3.5-5 g/dLNormalS
1915-08-03Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
1915-04-13Leukocytes [#/volume] in Blood by Automated count9.410*3/uL4-11 10*3/uLNormalS
1915-04-13C reactive protein [Mass/volume] in Serum or Plasma11mg/L<=5 mg/LHighS
1915-04-13Potassium [Moles/volume] in Serum or Plasma3.4mmol/L3.5-5.1 mmol/LLowS
1915-04-13Creatinine [Mass/volume] in Serum or Plasma0.9mg/dL0.5-1.1 mg/dLNormalS
1915-04-13Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L<=33 U/LNormalS
1915-10-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1915-10-19Total score [AUDIT-C]0{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1915-01-19Body height160cmS
1915-01-19Body weight45kgS
1915-01-19Body mass index (BMI) [Ratio]17.6kg/m2S
1915-01-19Systolic blood pressure104mm[Hg]S
1915-01-19Diastolic blood pressure66mm[Hg]S
1915-01-19Heart rate96/minS
1915-01-19Respiratory rate16/minS
1915-01-19Body temperature37.6CelS
1915-01-19Oxygen saturation in Arterial blood by Pulse oximetry99%S
1915-01-28Body height160cmS
1915-01-28Body weight44.8kgS
1915-01-28Body mass index (BMI) [Ratio]17.5kg/m2S
1915-01-28Systolic blood pressure102mm[Hg]S
1915-01-28Diastolic blood pressure64mm[Hg]S
1915-01-28Heart rate92/minS
1915-01-28Respiratory rate16/minS
1915-01-28Body temperature37.4CelS
1915-01-28Oxygen saturation in Arterial blood by Pulse oximetry99%S
1915-03-02Body height160cmS
1915-03-02Body weight46.4kgS
1915-03-02Body mass index (BMI) [Ratio]18.1kg/m2S
1915-03-02Systolic blood pressure108mm[Hg]S
1915-03-02Diastolic blood pressure68mm[Hg]S
1915-03-02Heart rate84/minS
1915-03-02Respiratory rate14/minS
1915-03-02Body temperature36.8CelS
1915-03-02Oxygen saturation in Arterial blood by Pulse oximetry99%S
1915-04-27Body height160cmS
1915-04-27Body weight48.4kgS
1915-04-27Body mass index (BMI) [Ratio]18.9kg/m2S
1915-04-27Systolic blood pressure106mm[Hg]S
1915-04-27Diastolic blood pressure68mm[Hg]S
1915-04-27Heart rate76/minS
1915-04-27Respiratory rate14/minS
1915-04-27Body temperature36.7CelS
1915-04-27Oxygen saturation in Arterial blood by Pulse oximetry99%S
1915-08-03Body height160cmS
1915-08-03Body weight50.6kgS
1915-08-03Body mass index (BMI) [Ratio]19.8kg/m2S
1915-08-03Systolic blood pressure108mm[Hg]S
1915-08-03Diastolic blood pressure70mm[Hg]S
1915-08-03Heart rate72/minS
1915-08-03Respiratory rate14/minS
1915-08-03Body temperature36.6CelS
1915-08-03Oxygen saturation in Arterial blood by Pulse oximetry99%S
1915-04-13Body height160cmS
1915-04-13Body weight46.9kgS
1915-04-13Body mass index (BMI) [Ratio]18.3kg/m2S
1915-04-13Systolic blood pressure98mm[Hg]S
1915-04-13Diastolic blood pressure62mm[Hg]S
1915-04-13Heart rate98/minS
1915-04-13Respiratory rate16/minS
1915-04-13Body temperature37.7CelS
1915-04-13Oxygen saturation in Arterial blood by Pulse oximetry99%S
1915-10-19Body height160cmS
1915-10-19Body weight51.4kgS
1915-10-19Body mass index (BMI) [Ratio]20.1kg/m2S
1915-10-19Systolic blood pressure108mm[Hg]S
1915-10-19Diastolic blood pressure68mm[Hg]S
1915-10-19Heart rate70/minS
1915-10-19Respiratory rate14/minS
1915-10-19Body temperature36.6CelS
1915-10-19Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
1915-01-19Primary care visit for four months of abdominal pain, diarrhea, fevers, and weight lossfinishedS
1915-01-28Diagnosis of Crohn disease with intestinal tuberculosis excluded; inflammatory bowel disease consultation the same dayfinishedS
1915-03-02Review at week 4 of risankizumab, on the day of the second induction infusionfinishedS
1915-04-27Review at week 12, the first maintenance dose of risankizumabfinishedS
1915-08-03Six-month review on maintenance risankizumabfinishedS
1915-04-13Same-day sick visit for vomiting and diarrhea on risankizumabfinishedS
1915-10-19Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Workup for suspected inflammatory bowel disease: blood count, CRP, albumin, iron studies, vitamin B12 and D, fecal calprotectin, stool tests for Clostridioides difficile and enteric pathogens, celiac serology, a pregnancy test, ileocolonoscopy with biopsies, and MR enterographycompletedGL-ACG-CD-2025, GL-ECCO-ESGAR-2019S
Exclude intestinal tuberculosis before any steroid or immunosuppressive drug: interferon-gamma release assay, chest X-ray, and ileal and colonic biopsies for acid-fast stain, TB PCR, and mycobacterial culture; with hepatitis B, hepatitis C, HIV, measles, and varicella serology before treatmentcompletedGL-ECCO-INF-2026, GL-ACG-CD-2025S
Gastroenterology (inflammatory bowel disease) consultation once the endoscopy and imaging are done, to confirm the diagnosis and choose treatment with hercompletedGL-ACG-CD-2025, GL-AGA-CD-2021S
Nutrition: dietitian assessment, small frequent meals with oral nutritional supplements, and weight at every visitcompletedGL-ECCO-CD-2024, GL-ACG-PREV-2025S
Mood, anxiety, and work: PHQ-9 and GAD-7 at intervals, IBD psychology if needed, and a practical plan for composing and performing during treatmentcompletedGL-ACG-PREV-2025S
Risankizumab 600 mg intravenously at weeks 0, 4, and 8, then 360 mg subcutaneously every 8 weeks, chosen with her as early advanced therapy; liver enzymes and bilirubin at baseline and through at least week 12; a short prednisone bridge tapered over eight weeks; no live vaccinescompletedGL-ACG-CD-2025, GL-AGA-CD-2021, GL-ECCO-CD-2024, GL-FDA-RISANKIZUMAB-2026S
Vaccines before immunosuppression: PCV20, recombinant zoster vaccine in two doses, a hepatitis B booster with an antibody check one to two months later, and influenza and COVID-19 vaccines each season; live vaccines not needed because she is immune to measles and varicellacompletedGL-ACG-PREV-2025, GL-CDC-IMZ-2026, GL-ECCO-INF-2026S
Iron, vitamin D, and bone: one intravenous ferric derisomaltose infusion, vitamin D3 daily, calcium while on prednisone, baseline DXA, and weight-bearing exercisecompletedGL-ACG-PREV-2025, GL-ECCO-CD-2024S
Treat to target: symptoms and CRP at every visit, fecal calprotectin at about three and six months, and ileocolonoscopy at six to twelve monthscompletedGL-STRIDE-2021, GL-ACG-CD-2025S
Contraception, fertility, and pregnancy planning: effective contraception while the disease is active; plan pregnancy after three to six months of steroid-free remission, with a preconception review; continue the biologic in pregnancy after discussing the limited data for risankizumab; folic acid before conceptioncompletedGL-PREG-IBD-2025, GL-FDA-RISANKIZUMAB-2026S

Goals

GoalTargetStatusOutcomeProvenance
Reach a diagnosis, with tuberculosis excluded, within two weeks1915-01-28completedIleocolonoscopy, biopsies, MR enterography, interferon-gamma release assay, and chest X-ray completed in nine days; Crohn disease diagnosed and intestinal tuberculosis made very unlikely, with the mycobacterial culture still pendingS
Steroid-free clinical remission by week 12 to 16 of treatment1915-04-27completedHarvey-Bradshaw Index 2 at week 12, five weeks after the prednisone taper endedS
Normal CRP and fecal calprotectin by six months, and endoscopic response at six to twelve months1915-10-05completedCRP 2 mg/L and calprotectin 42 ug/g at six months; SES-CD 14 to 2 at eight monthsS
Regain weight to a BMI of 19 or more and correct iron and vitamin D1915-08-03completedWeight 50.6 kg (BMI 19.8); hemoglobin 13.1, ferritin 72, vitamin D 34S
Perform her March concert and keep composing through treatment1915-04-27completedComposing most mornings; the concert went ahead in late March with a plan for bathroom accessS

Functional Status

Mental Status